KRAS and type 2 diabetes mellitus: In particular, visceral obesity, a high-fat diet, T2DM, IGF release and hyperinsulinemia are associated with pancreatic duct cell proliferation, pancreatic stellate cell activation, TGF-β1 release, pancreatic fibrosis and KRAS activation.